NRSN
NEUROSENSE (NRSN)
NASDAQ
$0.80+$0.003 (+0.38%)
Price as of Jun 03, 2026 6:06 PM EDT
  • N/A
    Market Cap
  • -54.02%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
47,000
+4.44%
45,000
N/A
N/A
N/A
N/A
N/A
Gross Profit
-47,000
+4.44%
-45,000
N/A
0
N/A
0
N/A
Sales and Marketing Expense
219,000
+63.43%
134,000
-92.98%
1.9M
N/A
N/A
N/A
Research and Development Expense
-6.2M
+9.28%
-5.7M
+540.94%
-889,000
-44.16%
-1.6M
-19.15%
Depreciation and Amortization Expense
16,000
-27.27%
22,000
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
4.9M
+15.56%
4.2M
-26.43%
5.7M
-19.93%
7.1M
+184.87%
Operating Profit
-11.1M
+11.95%
-9.9M
-25.56%
-13.3M
-1.84%
-13.6M
+142.56%
Interest Income
13,000
+550.00%
2,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
13,000
+550.00%
2,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-40,000
-87.01%
-308,000
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-11.1M
+11.95%
-9.9M
-12.22%
-11.3M
-8.59%
-12.3M
+205.37%
Income Taxes
2.9M
+272.63%
782,000
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-11.1M
+8.96%
-10.2M
-9.49%
-11.3M
-8.59%
-12.3M
+205.37%
Net Income from Continuing Operations Applicable to Common
-11.1M
+8.96%
-10.2M
-9.49%
-11.3M
-8.59%
-12.3M
+205.37%
Basic EPS and Net Income
-0.44
-18.52%
-0.54
-34.94%
-0.83
-22.43%
-1.07
+64.62%
Diluted EPS and Net Income
-0.44
-18.52%
-0.54
-34.94%
-0.83
-22.43%
-1.07
+64.62%
Basic Weighted Average Shares
25.5M
+36.98%
18.6M
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
25.5M
+36.98%
18.6M
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
166,000
-95.09%
3.4M
+27.95%
2.6M
-25.49%
3.5M
-67.97%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
166,000
-95.09%
3.4M
+27.95%
2.6M
-25.49%
3.5M
-67.97%
Total Current Assets
778,000
-82.33%
4.4M
+50.96%
2.9M
-60.49%
7.4M
-35.32%
Accumulated Depreciation
63,000
+16.67%
54,000
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
58,000
-12.12%
66,000
-22.35%
85,000
+10.39%
77,000
+305.26%
Total Long-Term Assets
250,000
+44.51%
173,000
-33.46%
260,000
-20.97%
329,000
+1,631.58%
Total Assets
1.0M
-77.53%
4.6M
+44.05%
3.2M
-58.81%
7.7M
-32.55%
Income Taxes Payable
1.2M
+345.21%
261,000
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.5M
+26.31%
2.0M
-42.41%
3.5M
+100.41%
1.7M
+189.11%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
72,000
-1.37%
73,000
-95.41%
1.6M
+335.89%
365,000
-80.03%
Total Liabilities
2.6M
+29.92%
2.0M
-60.55%
5.0M
+141.51%
2.1M
-13.77%
Retained Earnings
-47.8M
+30.35%
-36.7M
+14.33%
-32.1M
+54.27%
-20.8M
+146.10%
Total Stockholders Equity
-1.6M
-160.39%
2.6M
+237.83%
-1.9M
-133.35%
5.6M
-37.61%
Total Shares Outstanding
32.6M
+40.16%
23.2M
+645,148.36%
3,600
-95.00%
72,000
N/A
Cash Flow
Cash from Operating Activities
-7.7M
-24.31%
-10.1M
+19.91%
-8.5M
+11.42%
-7.6M
+392.92%
Capital Expenditures
8,000
+166.67%
3,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-8,000
-900.00%
1,000
-99.97%
3.6M
+202.97%
-3.5M
+20,729.41%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.4M
-59.39%
10.9M
+180.18%
3.9M
+5.41%
3.7M
-68.95%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-397.11%
+50.73%
-263.45%
+27.12%
-207.24%
+60.73%
-128.94%
N/A
Return on Equity
-2,174.98%
-24.48%
-2,880.11%
+378.10%
-602.40%
+256.98%
-168.75%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.31
-86.01%
2.21
+162.14%
0.84
-80.29%
4.28
N/A
Cash Ratio
0.07
-96.11%
1.70
+122.20%
0.76
-62.82%
2.05
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow